Articles tagged with Human Immunodeficiency Virus
Researchers found that delirium in critically ill patients is associated with higher mortality and disability rates at six months after discharge. The study evaluated 711 patients in Zambia and found that delirium occurred in 48.5% of cases, predicting higher odds of mortality and disability.
A new study finds that self-testing increased HIV testing rates by over 93% amongst trans participants, but highlights the need for inclusive and welcoming sexual health services. The study's findings suggest that most existing services do not meet the unique needs of this community.
A study in rural Kenya and Uganda found that offering universal access to pre-exposure prophylaxis (PrEP) significantly reduced HIV incidence, particularly among women. The study suggests that providing broad access to PrEP alongside HIV testing and treatment could reduce new HIV infections in generalized epidemic settings.
A study by Columbia University's Mailman School of Public Health found that perceived racism, sexual orientation discrimination, and HIV-status discrimination are associated with increased risk for criminal justice involvement. The research highlights the compounding effect of intersecting forms of social inequality on health outcomes.
A new study published in The Lancet HIV found that integrating opioid use disorder treatment with HIV care in Vietnam can be effective. The study suggests that countries aiming to expand treatment should consider interventions supporting retention on treatment through family networks, peers, and community health workers.
A new study in South Africa found that male clients of female sex workers contribute significantly to HIV transmission, with a rate of 6.9% over a decade. Increasing treatment among these individuals could reduce transmission by up to five times, making them a key focus for HIV prevention and treatment efforts.
Researchers at WashU Medicine have identified a potential way to eradicate latent HIV infection by triggering a natural alarm system in human immune cells. The strategy targets the activity of a specific HIV protein, rather than its appearance, and has shown promise with certain drugs that force the protein to become active.
A study in New York State found COVID-19 hospitalization rates were higher among those living with diagnosed HIV compared to those without. The results highlight the increased risk of severe illness in individuals with HIV during the pandemic.
Researchers found that MB66, a vaginal film product containing monoclonal antibodies, is safe and effective in preventing HIV-1 and HSV-2. The product provided excellent antiviral protection for up to 24 hours after use, with high acceptability among women.
A recent study found that Medicaid expansion led to a significant increase in the identification of undiagnosed HIV infections and the use of HIV prevention services. The research reveals a 13.9% rise in new HIV diagnoses, mostly concentrated among injection drug users in low-income and rural counties.
A study of people living with HIV in Ethiopia found that poverty and labor mobility are associated with high viral loads, indicating treatment failure. The researchers highlight the importance of considering socioeconomic conditions in low-income countries to ensure effective HIV treatment.
Researchers analyzed MRI data from 1203 HIV-positive individuals across 5 continents, finding smaller brain volumes associated with lower white blood cell counts. The study highlights the importance of understanding how HIV infection affects the brain, particularly in the context of aging and treatment.
MIT researchers have created a new computational model that can predict which sections of viral surface proteins are more likely to mutate in a way that enables viral escape. The model identifies potential targets for vaccines against influenza and HIV, offering hope for developing effective treatments.
A recent study published in the Chinese Medical Journal found a high proportion of recent HIV infections among Chinese MSM college students, particularly those under 25 years old. The study suggests that regular HIV testing and TDR testing are crucial to prevent the spread of the disease. The findings highlight the need for early educa...
A mathematical model developed by researchers predicts that autologous gene-edited stem cell transplants could achieve viral control after antiretroviral therapy withdrawal. The conditions required for this include a sufficient dose of edited stem cells and allowing them to repopulate the blood before ART is stopped.
Researchers will develop a low-tech virtual village platform to connect people living with HIV, providing resources and social support. The study aims to reduce depression, anxiety, and isolation among seniors aging with HIV during the COVID-19 pandemic.
A recent study investigated attitudes towards long-acting injectable (LAI) HIV therapies among women with a history of injection, including medical purposes and substance use. The research found that LAIs may improve adherence by reducing treatment fatigue and reminders associated with daily pill-taking.
New research reveals that people with HIV are more likely to experience cardiovascular disease, with impaired blood vessel function playing a significant role. The study also found that kidney function had a stronger connection to blood vessel health in those with HIV.
A new study from Drexel University demonstrates the effectiveness of integrating pre-exposure prophylaxis (PrEP) with syringe exchange services for women who inject drugs. The pilot program resulted in high PrEP adoption rates and improved HIV prevention outcomes, highlighting the potential for co-located services to address health dis...
Researchers at Texas Biomed will study the effects of cannabinoids on Human Immunodeficiency Virus (HIV) associated neurocognitive disorder (HAND), with a focus on delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD). The goal is to develop better therapeutic options for HIV patients suffering from HAND.
Researchers are developing a novel 'food as medicine' intervention to address high rates of food insecurity and insulin resistance in Oklahoma's HIV community. The five-year project will test the impact of diet on insulin resistance and chronic inflammation, with a focus on identifying community-based solutions.
Researchers have developed a new method to identify adaptive mutations in complex evolving populations, shedding light on how HIV mutates to escape the immune system. The approach enables the analysis of selection in complex evolutionary systems, which could inform HIV vaccine design and treatment strategies.
New research from Lehigh University explores the link between drought, food insecurity, and HIV among women in less-developed countries. The study finds that drought escalates food insecurity, leading to reduced access to education, healthcare, and autonomy, ultimately increasing the percentage of HIV cases among women.
A new statistical physics method reveals patterns of selection in HIV evolution, distinguishing adaptive mutations from random variations. This approach could inform HIV vaccine design and develop better treatments against the virus.
The European Centre for Disease Prevention and Control (ECDC) and the World Health Organization (WHO) are urging increased HIV testing in Europe to combat late diagnoses. More than 136,000 people were newly diagnosed with HIV in 2019, with 53% of those diagnosed at a late stage of the infection.
Researchers at Scripps Research successfully generated antibodies against multiple strains of HIV in mice using genetically engineered immune cells. The approach shows promise for preventing new HIV infections and potentially offering a functional cure for those with HIV/AIDS.
Researchers have discovered the three-dimensional structure of Nef-CD4 and AP-2, providing a basis for developing anti-HIV therapies. This finding highlights Nef's crucial role in subverting human cells' defense mechanisms, enabling HIV replication and disease progression.
Integrating HIV self-testing into Canada's health system could lead to better HIV detection and management, especially for underdiagnosed populations. The authors propose four factors for successful introduction, including rapid approval of WHO-approved tests and cost-effectiveness studies.
A new study led by Boston Medical Center researchers identified the inability to control HIV RNA production from existing HIV DNA as a potential key driver of chronic inflammation in people living with HIV. This finding highlights the need for novel treatments targeting persistent inflammation to improve outcomes.
Researchers developed a new imaging method that maps HIV's sugary shield in unprecedented detail, shedding light on its structure and dynamic nature. The technique has the potential to improve vaccine design by targeting vulnerable sites on HIV and other glycan-shielded viruses.
Penn State researchers are creating a new method to monitor HIV treatment effectiveness at home. The device will enable patients to use a finger prick test and reduce hospital visits to check their viral loads, reducing mortality and morbidity rates.
A research team at George Washington University is exploring the role of sex hormones in HIV latency and its impact on treatment efficacy. The study aims to develop more effective approaches to a cure for HIV, particularly for women and transgender patients who are disproportionately affected by the virus.
Researchers found that supplementing people with HIV with GlyNAC, a combination of glycine and N-acetylcysteine, improves multiple deficits associated with premature aging. The supplement boosts glutathione levels, a natural antioxidant that neutralizes free radicals and helps maintain cellular function.
The Society for Healthcare Epidemiology of America has updated its guidance for healthcare personnel living with HIV or hepatitis, citing low transmission rates and advances in treatments. The new recommendations aim to protect both patients and healthcare workers while ensuring privacy and health.
Researchers in Lesotho and Switzerland found that combining home visits with HIV self-tests increased test coverage among villagers, particularly young people. The strategy resulted in a 20% higher HIV test rate compared to traditional campaigns.
Researchers recreated HIV infection steps in a test tube, identifying essential components for replication. The study provides an unprecedented view of the virus and its role in infection, shedding light on potential targets for improved treatments.
Researchers found that a majority of HIV-specific T cells can detect and respond to viruses with the capacity to rebound following treatment interruptions. This knowledge could contribute to the development of new treatments against HIV infection. The study suggests that T cells play a crucial role in controlling viral rebound.
The Chicago Center for HIV Elimination has been awarded $5 million to implement a COVID-19 testing project targeting low-income Latinx individuals and those with criminal justice backgrounds. The project will use an evidence-based Social Network Testing Strategy to increase testing rates among these populations.
The Ezintsha study found that newer regimens containing dolutegravir and tenofovir alafenamide demonstrate a large increase in weight, especially in women. The study showed that all three regimens were potent and well-tolerated by patients, but the newer regimens had more side effects and resistance benefits over older regimens.
Researchers have mapped out an atlas of the latent virus reservoir cells of eight individuals living with HIV, challenging previous assumptions about its makeup. The study used a new approach to backtrack reactivated reservoir cells to their original latent state, revealing distinct areas and shared markers across different tissue types.
A recent study found patients with HIV who contract COVID-19 are at higher risk of hospitalization and death due to low immunity. Older adults and those with chronic health issues are particularly vulnerable.
Federal regulations severely limit corneal donations from gay and bisexual men, preventing thousands of potential patients from receiving vision-restoring surgery. A new study finds that the restrictions are not supported by current science and could save thousands of lives.
Researchers have developed a new Dual CAR T cell immunotherapy that targets the HIV reservoir and combats HIV infection in humanized mice. The therapy, which combines two CARs into a single T cell, provides a strong and long-lasting response against HIV-infection while being resistant to the virus itself.
A five-year grant from the National Cancer Institute will support research on cancer prevention and treatment in people living with HIV. The grant will focus on high-risk populations and aim to complete the ANCHOR Study, which investigates anal cancer prevention.
A new study explores women's hesitancy to use long-acting injectable (LAI) PrEP and their interest in its benefits. Women reported preferring LAI PrEP due to perceived effectiveness, convenience, and confidentiality.
A study reveals that structural and systemic racism significantly impact HIV care for Black women in the US South, leading to decreased trust in healthcare providers and systems. The findings highlight the need for addressing mistrust issues and empowering patients through effective communication and community-based interventions.
A study by Vanderbilt University Medical Center found that only 54% of medical practitioners have prescribed pre-exposure prophylaxis (PrEP) to HIV-vulnerable patients, highlighting a need for increased adoption of the preventive medication.
New HIV treatments may increase weight, but surprisingly limit cardiovascular risk due to increased leptin levels. Leptin therapy has restored vascular function in patients with lipodystrophy.
A team of researchers has discovered a novel approach to combat HIV using an antibiotic molecule called concanamycin A. The compound inhibits the Nef protein, allowing cytotoxic T lymphocytes to recognize and destroy HIV-infected cells. This breakthrough offers new hope for a potential cure for HIV by combining with existing treatments.
A recent study examined the pharmacist's role in HIV care in France, revealing that only 40% of pharmacists systematically offer online patient medication files to people living with HIV. The survey also found that 7% of those who were offered medication interviews felt well taken care of.
Critics argue that male circumcision campaigns in Africa are not based on robust science but on racist assumptions about culture, health, and sexuality. The campaigns have been carried out without sufficient contextual research and with underrepresentation of African voices.
A new study finds that states with HIV criminalization laws have lower PrEP uptake rates, while those with nondiscrimination laws for sexual minorities have higher rates. The researchers call for state governments to repeal criminalization laws and improve access to HIV treatment and prevention.
A 2018 survey found that 28% of organizations stopped or reduced at least one service in response to the policy, including reproductive health services. The current policy may negatively affect PEPFAR beneficiaries, particularly youth and pregnant women.
The BEAT-HIV Collaboratory recommends prioritizing viral measurements to accurately measure persistent HIV reservoirs in cure-directed clinical studies. These guidelines aim to standardize measurement approaches and aid researchers in their quest to find a cure for HIV.
A study found that rapid testing for HIV and HCV at drug detoxification centers led to a higher number of positive test results compared to laboratory-based testing. This approach has the potential to improve healthcare access for individuals with substance use disorders, reducing the risk of transmission and improving treatment outcomes.
Researchers at Keck School of Medicine of USC have received a five-year, $14.6 million grant to advance gene therapy for HIV control without daily medicines. The approach is inspired by three cases of HIV cure and aims to prepare patients for stem cell transplants with little toxicity.
A study found that approximately one-third of HIV patients in Malawi's Zomba Hospital had significant levels of HIV in their blood, with over 80% resistant to multiple antiretroviral drugs. Patients with multidrug-resistant HIV were 70% more likely to die within two months.
A Commentary in AIDS Patient Care and STDs finds COVID-19 and HIV diagnoses decreasing as white population increases in US counties. Systemic racism is a key factor contributing to disparities in health outcomes among communities of color.
Research reveals that HIV studies are often designed with an unrepresentative population, leading to a lack of effective solutions for diverse groups. The study's findings highlight the need for more inclusive research methods to address health inequalities and improve patient outcomes.
Researchers found that elite HIV controllers have viral reservoirs located in inactive regions of the genome, known as gene deserts, which are incapable of reactivating. This unique characteristic may hold the key to achieving a functional cure for HIV by targeting active viral reservoirs.